Home
Vista Pharmaceuticals Ltd PE Ratio

Vista Pharmaceuticals Ltd
NSE: VISTAPHARMA
PE
Key Highlights
- The P/E Ratio of Vista Pharmaceuticals Ltd is 0 as of 19 Apr 11:41 AM .
- The P/E Ratio of Vista Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
- The Latest Trading Price of Vista Pharmaceuticals Ltd is ₹ 11.3 as of 17 Apr 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Vista Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Vista Pharmaceuticals Ltd
Company Fundamentals for Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd
NSE: VISTAPHARMA
Share Price
Market Price of Vista Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
17 Apr 2025 | 11.3 |
16 Apr 2025 | 10.93 |
15 Apr 2025 | 11.5 |
11 Apr 2025 | 11.8 |
09 Apr 2025 | 11.5 |
08 Apr 2025 | 11.81 |
07 Apr 2025 | 12.22 |
04 Apr 2025 | 12.49 |
03 Apr 2025 | 11.94 |
02 Apr 2025 | 11.43 |
SWOT Analysis Of Vista Pharmaceuticals Ltd
BlinkX Score for Vista Pharmaceuticals Ltd
Asset Value vs Market Value of Vista Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Vista Pharmaceuticals Ltd | 43.87 | - |
Sun Pharmaceutical Industries Ltd | 420136 | 35.6 |
Divis Laboratories Ltd | 149680 | 72.4 |
Cipla Ltd | 122390 | 24.5 |
Torrent Pharmaceuticals Ltd | 110154 | 59.2 |
Mankind Pharma Ltd | 106555 | 52.2 |
Company | |
---|---|
Vista Pharmaceuticals Ltd | 43.87 |
Sun Pharmaceutical Industries Ltd | 420136 |
Divis Laboratories Ltd | 149680 |
Cipla Ltd | 122390 |
Torrent Pharmaceuticals Ltd | 110154 |
Mankind Pharma Ltd | 106555 |
PE Ratio of Vista Pharmaceuticals Ltd Explained
₹43.87
Market cap
₹-3
Earnings
0.0X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Vista Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Vista Pharmaceuticals Ltd
Historical Revenue, EBITDA and Net Profit of Vista Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Vista Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Vista Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Vista Pharmaceuticals Ltd
About Vista Pharmaceuticals Ltd
- Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991.
- The Company is engaged in the formulation of pharmaceutical products.
- It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
- This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India. The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
- Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.
Vista Pharmaceuticals Ltd News Hub
Vista Pharmaceuticals reports standalone net loss of Rs 0.86 crore in the June 2024 quarter
Net Loss of Vista Pharmaceuticals reported to Rs 0.86 crore in the quarter ended June 2024 as agains
Read more
14 Aug 24
Vista Pharmaceuticals to discuss results
Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024
Read more
06 Aug 24
Vista Pharmaceuticals to conduct AGM
Vista Pharmaceuticals announced that the 33th Annual General Meeting (AGM) of the company will be he
Read more
10 Sept 24
Vista Pharmaceuticals reports standalone net loss of Rs 0.97 crore in the September 2024 quarter
Net Loss of Vista Pharmaceuticals reported to Rs 0.97 crore in the quarter ended September 2024 as a
Read more
14 Nov 24